Laser-activated eye cancer drug developer Aura Biosciences scores $40M in Medicxi-led round - Endpoints News https://t.co/r4EopNtbQW
— IDRO (@IDROOhio) April 2, 2019
from Twitter https://twitter.com/IDROOhio
April 02, 2019 at 06:27AM
Tuesday, April 2, 2019
Laser-activated eye cancer drug developer Aura Biosciences scores $40M in Medicxi-led round - Endpoints News https://t.co/r4EopNtbQW
from Twitter https://twitter.com/IDROOhio
April 02, 2019 at 06:27AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment